within Pharmacolibrary.Drugs.ATC.S;

model S01AA19
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 90 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Ampicillin is a broad-spectrum beta-lactam antibiotic of the aminopenicillin class, primarily used to treat bacterial infections such as respiratory tract infections, urinary tract infections, meningitis, salmonellosis, and endocarditis. It is generally administered intravenously, intramuscularly or orally, and remains in clinical use today, with specific ophthalmic (S01AA19) use for ocular infections.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for ampicillin in healthy adult subjects following intravenous administration.</p><h4>References</h4><ol><li><p>Monaghan, KN, et al., &amp; Papich, MG (2021). Ampicillin pharmacokinetics in azotemic and healthy dogs. <i>Journal of veterinary internal medicine</i> 35(2) 987–992. DOI:<a href=&quot;https://doi.org/10.1111/jvim.16026&quot;>10.1111/jvim.16026</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33474795/&quot;>https://pubmed.ncbi.nlm.nih.gov/33474795</a></p></li><li><p>Apley, MD, et al., &amp; Gehring, R (2007). Ampicillin pharmacokinetics in swine following needle-free, intramuscular, and intravenous administration. <i>Journal of veterinary pharmacology and therapeutics</i> 30(5) 417–421. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2885.2007.00887.x&quot;>10.1111/j.1365-2885.2007.00887.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17803733/&quot;>https://pubmed.ncbi.nlm.nih.gov/17803733</a></p></li><li><p>Setiawan, E, et al., &amp; Roberts, JA (2023). Population Pharmacokinetics and Dosing Simulations of Ampicillin and Sulbactam in Hospitalised Adult Patients. <i>Clinical pharmacokinetics</i> 62(4) 573–586. DOI:<a href=&quot;https://doi.org/10.1007/s40262-023-01219-5&quot;>10.1007/s40262-023-01219-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36853585/&quot;>https://pubmed.ncbi.nlm.nih.gov/36853585</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01AA19;
